Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

347
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
347
Drug Delivery: Overview01:16

Drug Delivery: Overview

863
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
863
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
Reliability and Validity01:29

Reliability and Validity

13.9K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.9K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

832
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
832

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Molecular characterization and green synthesis of iron oxide nanoparticles from Ureibacillus chungkukjangi for methylene blue degradation.

Antonie van Leeuwenhoek·2026
Same author

Enhancing meat-type chicken performance through <i>Thymus vulgaris</i> leaf powder supplementation by affecting serum lipid profile, stress physiology, immunity, antioxidants, cecal microbiology, and jejunal histomorphology.

Archives animal breeding·2026
Same author

<i>Eucalyptus camaldulensis</i> Extract Mediated Green Synthesis of Iron Oxide Nanoparticles and In Vitro and In Vivo Biological Screening, and Detailed Molecular Docking Analysis.

Food science & nutrition·2026
Same author

Chondroitin sulfate and chondroitinase ABC: emerging roles in drug delivery and wound healing applications.

Journal of biomaterials science. Polymer edition·2026
Same author

Immunoinformatics-driven design of a multi-epitope vaccine against Seoul Virus: Structural, dynamic, and immunogenic profiling.

Clinics (Sao Paulo, Brazil)·2026
Same author

Trends in Helicobacter pylori seroprevalence among asymptomatic populations: Present findings and past evidence.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology·2026

Related Experiment Video

Updated: Feb 5, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.4K

Development and Validation of a Robust RP-HPLC Method for Quantifying Dasatinib in Self-Microemulsifying Drug

Nitin V Kokare1, Rohit R Shah2, Rana Salman Saad Al-Rashidi3

  • 1Department of Quality Assurance, Appasaheb Birnale College of Pharmacy, Sangli, 416416, Maharashtra, India.

International Journal of Analytical Chemistry
|February 4, 2026
PubMed
Summary

A new reverse-phase high-performance liquid chromatography (RP-HPLC) method accurately quantifies dasatinib in self-microemulsifying drug delivery systems (SMEDDSs). This validated method enhances dasatinib bioavailability for chronic myeloid leukemia treatment.

Keywords:
dasatinibdrug designformulationreverse-phase HPLCstabilityvalidation

More Related Videos

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.2K
Development and Validation of Chromium Getters for Solid Oxide Fuel Cell Power Systems
12:30

Development and Validation of Chromium Getters for Solid Oxide Fuel Cell Power Systems

Published on: May 26, 2019

7.8K

Related Experiment Videos

Last Updated: Feb 5, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.4K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.2K
Development and Validation of Chromium Getters for Solid Oxide Fuel Cell Power Systems
12:30

Development and Validation of Chromium Getters for Solid Oxide Fuel Cell Power Systems

Published on: May 26, 2019

7.8K

Area of Science:

  • Pharmaceutical Sciences
  • Analytical Chemistry

Background:

  • Dasatinib, a chronic myeloid leukemia (CML) therapy, exhibits poor oral bioavailability.
  • Self-microemulsifying drug delivery systems (SMEDDSs) are investigated to enhance dasatinib dissolution and bioavailability.

Purpose of the Study:

  • To develop and validate a novel reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantitative analysis of dasatinib.
  • To assess the suitability of the developed RP-HPLC method for dasatinib quantification within SMEDDS formulations.

Main Methods:

  • A RP-HPLC method was established using a methanol and 0.1% trifluoroacetic acid mobile phase (55:45, v/v) with detection at 324 nm.
  • Dasatinib quantification in SMEDDS formulations (Capryol 90, Transcutol HP, Tween 40) was performed.
  • Method validation was conducted according to International Council for Harmonisation (ICH) guidelines.

Main Results:

  • The RP-HPLC method demonstrated excellent linearity (R² = 0.9993), accuracy (98-101% recovery), and precision (RSD = 0.73%).
  • The method exhibited robust stability and reliability with low limits of detection (0.17 µg/mL) and quantification (0.50 µg/mL).

Conclusions:

  • The developed RP-HPLC method is validated and suitable for quantifying dasatinib in SMEDDS formulations.
  • This robust and cost-effective analytical tool supports the development and quality control of dasatinib-loaded SMEDDS.